Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Substituted bisphenyl butanoic acid derivatives as NEP inhibitors with improved in vivo efficacy

Substituted bisphenyl butanoic acid derivatives as NEP inhibitors with improved in vivo efficacy

US Patent 9102635 · Granted Aug 11, 2015

Estimated economic value: $10,682,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Substituted bisphenyl butanoic phosphonic acid derivatives as NEP inhibitors2018
Substituted bisphenyl butanoic phosphonic acid derivatives as NEP inhibitors2018
Bicyclic acetyl-CoA carboxylase inhibitors and uses thereof2017
2,3,5-trisubstituted thiophene compounds and uses thereof2016
Substituted bisphenyl butanoic phosphonic acid derivatives as NEP inhibitors2016
Substituted bisphenyl butanoic phosphonic acid derivatives as NEP inhibitors2016
Substituted bisphenyl butanoic phosphonic acid derivatives as NEP inhibitors2015
Substituted bisphenyl butanoic phosphonic acid derivatives as NEP inhibitors2015
2,3,5-trisubstituted thiophene compounds and uses thereof2015
Bicyclic acetyl-CoA carboxylase inhibitors and uses thereof2014
Cyclohexane derivatives and uses thereof2013
Furopyridine compounds and uses thereof2012